Takeda Pharmaceutical Co., Ltd. (TAK)
14.28
+0.02
(+0.14%)
USD |
NYSE |
Dec 10, 09:40
Takeda Pharmaceutical EPS Diluted (Quarterly): -0.0253 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Bristol Myers Squibb Co. | 1.079 |
| Johnson & Johnson | 2.121 |
| Novartis AG | 2.020 |
| Sanofi | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.53M |
| Revenue (Quarterly) | 7.546B |
| Total Expenses (Quarterly) | 7.626B |
| Enterprise Value | 71.88B |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -1.05% |
| Earnings Yield | 0.55% |
| Operating Earnings Yield | 7.20% |
| Normalized Earnings Yield | 1.307 |